Filing Details

Accession Number:
0001437749-23-017612
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-15 21:14:01
Reporting Period:
2023-06-13
Accepted Time:
2023-06-15 21:14:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI Pharmaceutical Preparations (2834) 770683487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589597 Edward Troy Wilson C/O Puma Biotechnolgy, Inc.
10880 Wilshire Boulevard, Suite 2150
Los Angeles CA 90024
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-13 27,000 $3.45 350 No 4 S Direct
Common Stock Acquisiton 2023-06-13 27,000 $0.00 27,350 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 400 Indirect By Child #1
Common Stock 150 Indirect By Child #2
Footnotes
  1. Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.